Drugplain

CUPRIC CHLORIDE .4 mg/mL

CUPRIC CHLORIDE · INJECTION, SOLUTION · Archis Pharma LLC

No Recall History
Plain English

CUPRIC CHLORIDE is a injection, solution containing cupric chloride at .4 mg/mL, taken intravenous. Manufactured by Archis Pharma LLC.

Key Facts

Brand Name
CUPRIC CHLORIDE
Generic Name
CUPRIC CHLORIDE
NDC Code (Product)
72819-234
Manufacturer
Archis Pharma LLC
Strength
.4 mg/mL
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS
Marketing Status
Application #
ANDA217626
Marketing Start
10/01/2024

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

hepatitis2 reports
acute respiratory failure1 reports
anaemia1 reports
blood potassium decreased1 reports
bone marrow failure1 reports
ceruloplasmin decreased1 reports
copper deficiency1 reports
covid-191 reports
death1 reports
disturbance in attention1 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

INDICATIONS AND USAGE Cupric chloride injection 0.4 mg/mL is indicated for use as a supplement to intravenous solutions given for total parenteral nutrition (TPN). Administration helps to maintain copper serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms.

Dosage & Administration

DOSAGE AND ADMINISTRATION Cupric Chloride Injection, USP 0.4 mg/mL contains 0.4 mg copper/mL and is administered intravenously only after dilution. The additive should be diluted in a volume of fluid not less than 100 mL. For the adult receiving TPN, the suggested additive dosage is 0.5 to 1.5 mg copper/day (1.25 to 3.75 mL/day). For pediatric patients, the suggested additive dosage is 20 mcg copper/kg/day (0.05 mL/kg/day). Infants weighing less than 1500 gm may have increased requirements because of their low body reserves and increased requirements for growth. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. (See PRECAUTIONS .)

Warnings

WARNINGS Direct intramuscular or intravenous injection of Cupric chloride injection 0.4 mg/mL is contraindicated, as the acidic pH of the solution (2) may cause considerable tissue irritation. Liver and/or biliary tract dysfunction may require omission or reduction of copper and manganese doses because these elements are primarily eliminated in the bile. WARNING: This product contains aluminum that may be toxic. Aluminum may reach toxic levels with prolonged parenteral administration if kidney function is impaired. Premature neonates are particularly at risk because their kidneys are immature, and they require large amounts of calcium and phosphate solutions, which contain aluminum. Research indicates that patients with impaired kidney function, including premature neonates, who receive parenteral levels of aluminum at greater than 4 to 5 mcg/kg/day accumulate aluminum at levels associated with central nervous system and bone toxicity. Tissue loading may occur at even lower rates of administration.

Contraindications

CONTRAINDICATIONS None known.

Adverse Reactions

ADVERSE REACTIONS None known.

Frequently Asked Questions

What is CUPRIC CHLORIDE used for?

CUPRIC CHLORIDE contains CUPRIC CHLORIDE. It is a injection, solution taken intravenous. Consult your doctor for specific uses.

Is CUPRIC CHLORIDE a controlled substance?

CUPRIC CHLORIDE is not classified as a controlled substance by the DEA.

What is the generic name for CUPRIC CHLORIDE?

The generic name for CUPRIC CHLORIDE is CUPRIC CHLORIDE. There are 2 other brand versions of CUPRIC CHLORIDE.

What is the NDC code for CUPRIC CHLORIDE .4 mg/mL?

The NDC (National Drug Code) for CUPRIC CHLORIDE .4 mg/mL is 72819-234, listed by Archis Pharma LLC.

Product NDC

72819-234

Package NDC

72819-234-99

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)